FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Cadista Pharmaceuticals Pantoprazole Sodium Delayed Release Tablets Recall

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, R…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class II
Reported by FDA
Oct 23, 2019
Recall ID
D-0145-2020
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Pantoprazole Sodium Delayed Release Tablets starting Sep 4, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0145-2020 on Oct 23, 2019. Reason: CGMP Deviation: Presence of dark brown discoloration on edges of tablets. Status: Terminated.

Why it was recalled

CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

Product description

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

Lot numbers, UPCs & expiration codes

Lot # PA218P008, PA218P009, Exp 04/2021

Where it was sold

Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0145-2020
Classification
Class II
Status
Terminated
Recall initiated
Sep 4, 2019
FDA report date
Oct 23, 2019
Quantity
63,216 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0145-2020, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
83705
Address
207 Kiley Dr
Code information
Lot # PA218P008, PA218P009, Exp 04/2021
Postal code
21801-2249
Report date
Oct 23, 2019
Product type
Drugs
Recall number
D-0145-2020
Classification
Class II
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
63,216 bottles
Termination date
Feb 12, 2020
Reason for recall
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90
Distribution pattern
Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.
Recall initiation date
Sep 4, 2019
Initial firm notification
Letter
Center classification date
Oct 17, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0145-2020, published Oct 23, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls